Medanta Reinforces Leadership in Neurological Care with Advanced ‘Brain Pacemaker’ Surgery
Dehradun, 09 May 2026: The global burden of neurological disorders has increased significantly over the past few decades, making them a leading cause of disability. In India, they now account for nearly 10% of the total disease burden.
Medanta –The Medicity, ranked India’s best hospital by Newsweek in 2026, is an internationally recognised destination for Deep Brain Stimulation (DBS), widely known as ‘Brain Pacemaker’ surgery. This treatment combines cutting-edge technology with personalised care to provide meaningful relief to patients suffering from disabling neurological conditions such as advanced-stage Parkinson’s disease, dystonia, refractory epilepsy (adult onset), essential tremor, and advanced obsessive-compulsive disorder (OCD).
Led by Dr. Anirban Deep Banerjee, Director, Neurosurgery, Institute of Neurosciences at Medanta Gurugram, the neurostimulation procedure leverages advanced imaging for highly precise brain targeting. It integrates cutting-edge innovations such as directional leads for multi-dimensional neuromodulation and real-time brain-sensing biomarker feedback, enabling stimulation that adapts to patients’ symptoms. This approach broadens access to advanced care for people with serious neurological disorders, while offering renewed hope to patients and their loved ones.
As part of the DBS procedure, high-frequency electrical stimulation is delivered to specific areas of the brain using advanced neuroimaging for precise guidance. Regions are carefully identified based on the patient’s condition and symptom profile, ensuring accurate targeting. Once the target is defined, a thin wire with electrodes at its tip is implanted in the selected brain region to regulate abnormal neural activity. The stimulation generated by these electrodes helps modify these irregular signals, leading to improved symptom control.
Dr. Anirban Deep Banerjee, Director, Neurosurgery, Institute of Neurosciences at Medanta Gurugram said, “The success of brain pacemaker surgery lies in its precision and accuracy. Deep Brain Stimulation (DBS) can effectively manage symptoms linked to neurological conditions, enabling patients to regain control over their bodies and daily lives. At Medanta, we are committed to expanding access to advanced treatments like DBS, supporting patients in improving their quality of life when medications and conventional therapies are no longer sufficient.”
Dr. Banerjee has performed more than 300 Deep Brain Stimulation (DBS) procedures over the past decade-and-a-half, achieving consistently high success rates. His extensive experience and outcomes have firmly established him as one of the most trusted and sought-after neurosurgeons for DBS surgery in India.
At Medanta, the DBS programme goes beyond conventional surgical expertise. It incorporates patient- and condition-specific advanced technologies, including AI-guided precision targeting of brain regions and remote programming capabilities. These innovations allow for highly personalised treatment and fine-tuning of therapy even after the procedure.